levamisole
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.
Pronunciation:
lee-vam-i-sole
Trade Name(s)
- Ergamisol
Ther. Class.
Pharm. Class.
immune response modifiers
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Levamisole." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109124/3/levamisole.
Vallerand AHA, Sanoski CAC. Levamisole. Davis's Drug Guide. F.A. Davis Company; 2026. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109124/3/levamisole. Accessed June 26, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Levamisole. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109124/3/levamisole
Vallerand AHA, Sanoski CAC. Levamisole [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 26]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109124/3/levamisole.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - levamisole
ID - 109124
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109124/3/levamisole
PB - F.A. Davis Company
ET - 20
DB - Nursing Central
DP - Unbound Medicine
ER -

Davis's Drug Guide

